The Influence of Proton Pump Inhibitor Use on the Gut Microbiome

Chan Hyuk Park; Sang Kil Lee

doi:10.4166/kjg.2016.68.5.288

Journal List > Korean J Gastroenterol > v.68(5) > 1007584

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Park and Lee: The Influence of Proton Pump Inhibitor Use on the Gut Microbiome

Research Update

Korean J Gastroenterol 2016;68(5):288-290.

Published online: 4 October 2016

DOI: https://doi.org/10.4166/kjg.2016.68.5.288

The Influence of Proton Pump Inhibitor Use on the Gut Microbiome

Chan Hyuk Park, Sang Kil Lee¹

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

¹Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Correspondence to: Sang Kil Lee, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: +82-2-2228-1996, Fax: +82-2-393-6884, E-mail: sklee@yuhs.ac

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Proton Pump Inhibitors Affect the Gut Microbiome

References

1. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006; 367:2086–2100.

2. Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016; 25:1079–1087.

3. Tleyjeh IM, Bin Abdulhak AA, Riaz M, et al. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and metaanalysis. PLoS One. 2012; 7:e50836.

4. Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015; 110:749–759.

5. Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and metaanalysis. PLoS One. 2015; 10:e0128004.

6. Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016; 65:740–748.

7. Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Proton pump inhibitors do not increase risk for clostridium difficile infection in the intensive care unit. Am J Gastroenterol. 2016. DOI: doi:10.1038/ajg.2016.343. [Epub ahead of print].

8. Washio E, Esaki M, Maehata Y, et al. Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: a randomized, placebo-controlled trial. Clin Gastroenterol Hepatol. 2016; 14:809–815.e1.

9. Blackler RW, Gemici B, Manko A, Wallace JL. NSAID-gastro- enteropathy: new aspects of pathogenesis and prevention. Curr Opin Pharmacol. 2014; 19:11–16.

10. Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011; 141:1314–1322. 1322.e1–5.

11. McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015; 175:784–791.

TOOLS

Similar articles